Dr. Jayaram S. Bharadwaj, MD

Dr. Bharadwaj practices at Los Angeles Cancer Network in Glendale, California.

Dr. Bharadwaj's NPI, 1083602155, was assigned on October 12, 2005. Dr. Bharadwaj graduated from M.S. Ramaiah Medical College in 1992. Dr. Bharadwaj's Missouri license number on file is 2002001982.

Dr. Bharadwaj's primary practice is Los Angeles Cancer Network, at 541 W Colorado St, Glendale, CA 91204 in Los Angeles County. The practice phone is (213) 977-1214.

Dr. Bharadwaj's primary practice is Los Angeles Cancer Network in Glendale, California. Dr. Bharadwaj is also affiliated with AHMC Anaheim Regional Medical Center. The medical group on file is Los Angeles Cancer Network. Dmand AI also links Dr. Bharadwaj to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bharadwaj practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bharadwaj's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bharadwaj is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bharadwaj's licenses on file in 5 states: Missouri, California, North Dakota, New Mexico and Kansas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Bharadwaj treats.

CMS data shows 9,982 Medicare services from Dr. Bharadwaj across 20 procedure codes in 2024, for 598 Medicare patients. Medicare paid $273,838 for them.

CMS counts 598 Medicare patients who saw Dr. Bharadwaj in 2024. The largest group is 65 to 74, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bharadwaj's median patient age at 66, with 61% women.

In 2024, Dr. Bharadwaj wrote 1,162 Medicare Part D claims for 165 patients. 61% of them were for generic drugs. CMS names the drug for 796 of them, across 29 drugs with 11 or more claims each, at $1,757,450 in total drug cost. In 2023, CMS named 503 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bharadwaj for performance year 2024, reported as part of a group. Dr. Bharadwaj accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bharadwaj as offering telehealth.

Dmand AI links 4 papers to Dr. Bharadwaj in 2020. Dr. Bharadwaj's most frequent co-authors are Richy Agajanian, MD, Shanta Chawla, MD and Patrick W. Cobb, MD.

Dmand AI links Dr. Bharadwaj to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 1,098 general payments to Dr. Bharadwaj from 90 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Seagen Inc. paid the most, $1,673.

Dmand AI lists 1 award for Dr. Bharadwaj, most recently CMS Stage 1 EHR in 2014.

Dr. Bharadwaj graduated from M.S. Ramaiah Medical College in 1992.

Dr. Bharadwaj is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.